Recruiting PHASE4 INTERVENTIONAL 2-arm NCT05440240

Percutaneous Needle Fasciotomy +/- Corticosteroid Injection for Dupuytren's Contracture

Percutaneous Needle Fasciotomy (PNF) +/- Corticosteroid Injection for Dupuytren's Contracture (DC) Affecting Metacarpophalangeal Joints (MCP) . A Randomized Controlled Trial

Sponsor: Regionshospitalet Silkeborg

Conditions Connective Tissue Diseases Contracture Dupuytren Contracture Dupuytren's Disease Fibroma Joint Diseases Musculoskeletal Diseases Neoplasm, Fibrous Tissue Neoplasms Neoplasms by Histologic Type Neoplasms, Connective Tissue Neoplasms, Connective and Soft Tissue

Interventions Corticosteroid injection Percutaneous needle fasciotomy Saline injection

Updated 5 times since 2022 Last updated: May 15, 2023 Started: Jan 10, 2023 Primary completion: Dec 31, 2025 Completion: Mar 31, 2030

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Connective Tissue Diseases and Contracture, this trial is actively recruiting participants. The trial is conducted by Regionshospitalet Silkeborg and has accumulated 5 data snapshots since 2023. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Recruiting PHASE4
Jul 2024 — Sep 2024 [monthly]

Recruiting PHASE4
Jun 2023 — Jul 2024 [monthly]

Recruiting PHASE4

Status: Not Yet Recruiting → Recruiting
Sep 2022 — Jun 2023 [monthly]

Not Yet Recruiting PHASE4
Jul 2022 — Sep 2022 [monthly]

Not Yet Recruiting PHASE4

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Regionshospitalet Silkeborg

Data source: Regionshospitalet Silkeborg

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Silkeborg, Denmark